Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;77(10):1069-1076.
doi: 10.1007/s40265-017-0744-y.

Advanced Analgesic Drug Delivery and Nanobiotechnology

Affiliations
Review

Advanced Analgesic Drug Delivery and Nanobiotechnology

Nicoleta Stoicea et al. Drugs. 2017 Jul.

Abstract

Transdermal administration of analgesic medications offers several benefits over alternative routes of administration, including a decreased systemic drug load with fewer side effects, and avoidance of drug degradation by the gastrointestinal tract. Transdermal administration also offers a convenient mode of drug administration over an extended period of time, particularly desirable in pain medicine. A transdermal administration route may also offer increased safety for drugs with a narrow therapeutic window. The primary barrier to transdermal drug absorption is the skin itself. Transdermal nanotechnology offers a novel method of achieving enhanced dermal penetration with an extended delivery profile for analgesic drugs, due to their small size and relatively large surface area. Several materials have been used to enhance drug duration and transdermal penetration. The application of nanotechnology in transdermal delivery of analgesics has raised new questions regarding safety and ethical issues. The small molecular size of nanoparticles enables drug delivery to previously inaccessible body sites. To ensure safety, the interaction of nanoparticles with the human body requires further investigation on an individual drug basis, since different formulations have unique properties and side effects.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

Nicoleta Stoicea, Juan Fiorda-Diaz, Nicholas Joseph, Muhammad Shabsigh, Carlos Arias-Morales, Alicia A. Gonzalez-Zacarias, Ana Mavarez-Martinez, Stephen Marjoribanks, and Sergio D. Bergese declare that they have no conflicts of interest to disclose.

Funding

All authors declare that they have no funding disclose.

Similar articles

Cited by

References

    1. Zhang YT, et al. An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers. J Pharm Sci. 2014;103(11):3602–3610. doi: 10.1002/jps.24152. - DOI - PubMed
    1. Carmona-Moran CA, et al. Development of gellan gum containing formulations for transdermal drug delivery: component evaluation and controlled drug release using temperature responsive nanogels. Int J Pharm. 2016;509(1–2):465–476. doi: 10.1016/j.ijpharm.2016.05.062. - DOI - PubMed
    1. Peptu C, et al. Nanotechnology approaches for pain therapy through transdermal drug delivery. Curr Pharm Des. 2015;21(42):6125–6139. doi: 10.2174/1381612821666151027152752. - DOI - PubMed
    1. Beck P, et al. Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models. J Microencapsul. 1993;10(1):101–114. doi: 10.3109/02652049309015316. - DOI - PubMed
    1. Conway MA, et al. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine. 2001;19(15–16):1940–1950. doi: 10.1016/S0264-410X(00)00433-3. - DOI - PubMed

LinkOut - more resources